| Translated title of the contribution | Phase I dose-escalation study of the safety and pharmacokinetics of Atrasentan: an endothelin receptor antagonist for refractory prostate cancer |
|---|---|
| Original language | Undefined/Unknown |
| Pages (from-to) | 2965-2972 |
| Number of pages | 8 |
| Journal | Clinical Cancer Research |
| Volume | 9 |
| Publication status | Published - 2003 |
Phase I dose-escalation study of the safety and pharmacokinetics of Atrasentan: an endothelin receptor antagonist for refractory prostate cancer
B.A. Zonnenberg, G. Groenewegen, T.J. Janus, T.W. Leahy, R.A. Humerickhouse, J.D. Isaacson, R.A. Carr, E.E. Voest
Research output: Contribution to journal › Article › Academic › peer-review